S1PR2 and Hyperammonemia: Hyperammonemia increased the IL-1β content in the hippocampus (139 ± 26%, p < 0.01), while blocking S1PR2 with JTE-013 completely reversed the increase in IL-1β (102 ± 17%; p < 0.05) (Figure 4e).